Pricing Log in Create free account

Enlivex Ltd. (ENLV) vs Liminatus Pharma Inc. (LIMN)

Enlivex Ltd. and Liminatus Pharma Inc. are both Biotechnology companies. Enlivex Ltd. and Liminatus Pharma Inc. are of similar size ($4.5M and $4.3M). Liminatus Pharma Inc. has negative trailing earnings, so its P/E is not meaningful; Enlivex Ltd. trades at 0.0×. Across the 10 metrics below, Enlivex Ltd. leads on 6 and Liminatus Pharma Inc. on 4.

Valuation

Metric ENLV LIMN Biotechnology median
P/E 0.00 n/m 8.50
P/S n/m n/m 9.71
P/B 0.00 9.79 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 240.66 n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield 248,526.43% (773.03%) (33.15%)
Free cash flow yield (301.79%) (135.00%) (25.50%)

Profitability

Metric ENLV LIMN Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 159.77% 294.43% (56.36%)
Return on assets 127.16% (471.47%) (48.04%)
Return on invested capital (5.85%) 0.00% 0.00%

Growth

Metric ENLV LIMN Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 3,590.26% (112.19%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ENLV LIMN Biotechnology median
Debt to equity 0.00 4.80 0.00
Current ratio 119.39 1.12 4.72
Net debt to EBITDA 118.29 (0.37) 0.96

Dividend

Metric ENLV LIMN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ENLV LIMN Biotechnology median
Market cap 4.46m 4.32m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack